DiaMedica Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

DiaMedica Therapeutics

28/03/2023 22:37

* DiaMedica Therapeutics Inc  DMAC.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 14 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * DiaMedica Therapeutics Inc's reported EPS for the quarter
was a
loss of 14 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * DiaMedica Therapeutics Inc shares had fallen by 1.6% this
quarter.
    * The company reported a quarterly loss of $3.75 million.
    * Wall Street's median 12-month price target for DiaMedica
Therapeutics Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 09:37 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.14          -0.14          Met
 Sep. 30 2022      -0.15          -0.12          Beat
 Jun. 30 2022      -0.18          -0.13          Beat
 Mar. 31 2022      -0.21          -0.13          Beat